新型冠状病毒核酸和抗体检测临床应用专家共识

2020-05-09 中国检验相关专家组 国际检验医学杂志.2020-5-9.

本共识经过上海医学会检验医学分会查阅文献、咨询相关专家的基础上进行编写,以对新型冠状病毒临床实验室检测、临床应用和生物安全提供有指导性的建议。本共识适用于从事新型冠状病毒核酸和血清抗体检测的临床实验室

中文标题:

新型冠状病毒核酸和抗体检测临床应用专家共识

发布机构:

中国检验相关专家组

发布日期:

2020-05-09

简要介绍:

本共识经过上海医学会检验医学分会查阅文献、咨询相关专家的基础上进行编写,以对新型冠状病毒临床实验室检测、临床应用和生物安全提供有指导性的建议。本共识适用于从事新型冠状病毒核酸和血清抗体检测的临床实验室,旨在规范我国新型冠状病毒核酸和抗体检测方法与流程,为临床提供规范可靠的检测结果与合理的报告解读。新型冠状病毒是一个全新的病毒,人类对新型冠状病毒的认识还在持续不断深入,本共识将适时修订,以适应临床应用的需求。

相关资料下载:
[AttachmentFileName(sort=1, fileName=新型冠状病毒核酸和抗体检测临床应用专家共识_关明.pdf)] GetToolGuiderByIdResponse(projectId=1, id=31dae1c0019230fe, title=新型冠状病毒核酸和抗体检测临床应用专家共识, enTitle=, guiderFrom=国际检验医学杂志.2020-5-9., authorId=0, author=, summary=本共识经过上海医学会检验医学分会查阅文献、咨询相关专家的基础上进行编写,以对新型冠状病毒临床实验室检测、临床应用和生物安全提供有指导性的建议。本共识适用于从事新型冠状病毒核酸和血清抗体检测的临床实验室, cover=https://img.medsci.cn/2020622/1592757283419_2020535.jpg, journalId=0, articlesId=null, associationId=762, associationName=中国检验相关专家组, associationIntro=null, copyright=0, guiderPublishedTime=Sat May 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>本共识经过上海医学会检验医学分会查阅文献、咨询相关专家的基础上进行编写,以对新型冠状病毒临床实验室检测、临床应用和生物安全提供有指导性的建议。本共识适用于从事新型冠状病毒核酸和血清抗体检测的临床实验室,旨在规范我国新型冠状病毒核酸和抗体检测方法与流程,为临床提供规范可靠的检测结果与合理的报告解读。新型冠状病毒是一个全新的病毒,人类对新型冠状病毒的认识还在持续不断深入,本共识将适时修订,以适应临床应用的需求。</p> </div> </div> </div>, tagList=[TagDto(tagId=7067, tagName=新型冠状病毒)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=7067, guiderKeyword=新型冠状病毒, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3123, appHits=82, showAppHits=0, pcHits=969, showPcHits=3041, likes=1, shares=15, comments=4, approvalStatus=1, publishedTime=Mon Jun 22 01:00:43 CST 2020, publishedTimeString=2020-05-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jun 22 00:34:47 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 09:50:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=新型冠状病毒核酸和抗体检测临床应用专家共识_关明.pdf)])
新型冠状病毒核酸和抗体检测临床应用专家共识_关明.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=951371, encodeId=a35e9513e13b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1255473477, createdName=ms6000000907097798, createdTime=Fri Mar 26 12:37:14 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903798, encodeId=0bac903e98a7, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dac1837858, createdName=ms2596152427230172, createdTime=Tue Dec 01 10:25:55 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884245, encodeId=6c3e88424516, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:02 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2021-03-26 ms6000000907097798

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=951371, encodeId=a35e9513e13b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1255473477, createdName=ms6000000907097798, createdTime=Fri Mar 26 12:37:14 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903798, encodeId=0bac903e98a7, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dac1837858, createdName=ms2596152427230172, createdTime=Tue Dec 01 10:25:55 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884245, encodeId=6c3e88424516, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:02 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-12-01 ms2596152427230172

    👍👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=951371, encodeId=a35e9513e13b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1255473477, createdName=ms6000000907097798, createdTime=Fri Mar 26 12:37:14 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903798, encodeId=0bac903e98a7, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dac1837858, createdName=ms2596152427230172, createdTime=Tue Dec 01 10:25:55 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884245, encodeId=6c3e88424516, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:02 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 120cac51m28暂无昵称

    0

拓展阅读

新型冠状病毒感染的肺炎防控方案(第二版)

中华人民共和国国家卫生健康委员会 · 2020-01-22

新型冠状病毒感染的肺炎诊疗方案(试行第三版)

中华人民共和国国家卫生健康委员会 · 2020-01-23

预防 2019 年新型冠状病毒 (2019-nCoV) 传播给家庭和社区中其他人的暂行指南

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2020-01-26

新型冠状病毒感染的肺炎诊疗方案(试行第五版)

中华人民共和国国家卫生健康委员会 · 2020-02-05